Differences between activities of coagulation factors after one month of therapy with different direct oral anticoagulant in pulmonary embolism patients-Reference-Cited by-同舟云学术

Differences between activities of coagulation factors after one month of therapy with different direct oral anticoagulant in pulmonary embolism patients

Published:2018-11-08 Issue:2 Volume:44 Page:236-242
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Dzudovic Jelena¹,Dzudovic Boris¹,Subota Vesna²,Antunovic Marko³,Stavric Milena²,Subotic Bojana¹,Obradovic Slobodan¹

Affiliation:

1. Clinic for Cardiology and Emergency Internal Medicine; Military Medical Academy; Belgrade Serbia

2. Institute for Medical Biochemistry; Military Medical Academy; Belgrade Serbia

3. National Poison Control Center; Military Medical Academy; Belgrade Serbia

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcpt.12776/fullpdf

Reference33 articles.

1. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism;Douketis;JAMA,1998

2. History of drugs for thrombotic disease. Discovery, development, and directions for the future;Mueller;Circulation,1994

3. Oral rivaroxaban for symptomatic venous thromboembolism;Brenner;N Engl J Med,2010

4. Oral apixaban for the treatment of acute venous thromboembolism;Agnelli;N Engl J Med,2013

5. Dabigatran versus Warfarin in the treatment of acute venous thromboembolism;Schulman;N Engl J Med,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding Pulmonary Embolism: Pathophysiology, Diagnosis, and Treatment;Biomedicines;2024-08-23

2. D-dimer for patients on VKA vs DOAC: impact on the validity of D-dimer to make decision for extended anticoagulation;Blood Advances;2024-07-10

3. D-Dimer and Fibrinogen Values according to the Localization of Deep Venous Thrombosis;International Journal of Angiology;2023-01-13

4. Research progress on biomarkers of pulmonary embolism;The Clinical Respiratory Journal;2021-08-03